Effect of growth hormone releasing hormone on chondrocytes of osteoarthritis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: To evaluate the effect and possible mechanism of growth hormone releasing hormone (GHRH) on chondrocytes of osteoarthritis (OA). Methods: Articular chondrocytes were cultured and the expression of GHRH receptor in chondrocytes was detected. Then recombinant adenovirus GHRH (Ad-GHRH) was transfected to one group of chondrocytes. The expression of collagen type II, matrix metalloproteinase 13 (MMP-13) and signal transducer and activator of transcription 3 (STAT3) in each experimental group was determined by Western blot. Results: The GHRH receptor was expressed in chondrocytes, and this provided a basis for further study of the role of GHRH in chondrocytes. Cell proliferation of the Ad-GHRH group was significantly higher than that of the OA group by CCK-8 assay. Compared with the OA-group, the protein expression of MMP‑13 was decreased in the Ad-GHRH group. Compared with the OA-group, the protein expression of collagen type II, phosphorylated STAT3 (P-STAT3) were increased in the Ad-GHRH group. Conclusions: Our results show that the GHRH receptor is expressed in chondrocytes. GHRH can promote the proliferation of chondrocytes and the synthesis of type II collagen, and increase the extracellular matrix, which is achieved by phosphorylated STAT3 protein.
Abstract
Background/Aims: To evaluate the effect and possible mechanism of growth hormone releasing hormone (GHRH) on chondrocytes of osteoarthritis (OA). Methods: Articular chondrocytes were cultured and the expression of GHRH receptor in chondrocytes was detected. Then recombinant adenovirus GHRH (Ad-GHRH) was transfected to one group of chondrocytes. The expression of collagen type II, matrix metalloproteinase 13 (MMP-13) and signal transducer and activator of transcription 3 (STAT3) in each experimental group was determined by Western blot. Results: The GHRH receptor was expressed in chondrocytes, and this provided a basis for further study of the role of GHRH in chondrocytes. Cell proliferation of the Ad-GHRH group was significantly higher than that of the OA group by CCK-8 assay. Compared with the OA-group, the protein expression of MMP‑13 was decreased in the Ad-GHRH group. Compared with the OA-group, the protein expression of collagen type II, phosphorylated STAT3 (P-STAT3) were increased in the Ad-GHRH group. Conclusions: Our results show that the GHRH receptor is expressed in chondrocytes. GHRH can promote the proliferation of chondrocytes and the synthesis of type II collagen, and increase the extracellular matrix, which is achieved by phosphorylated STAT3 protein.
참고문헌 (18)
- Chu CR, "Osteoarthritis : from palliation to prevention. AOA critical issues", J Bone Joint Surg Am, 96, pp.e130~ (2014)
- Karsdal MA, "Disease-modifying treatments for osteoarthritis(DMOADs)of the knee and hip : lessons learned from failures and opportunities for the future", Osteoarthritis Cartilage, 24, pp.2013~2021 (2016)
- Laires PA, "Years of working life lost caused by osteoarthritis in Portugal", Value Health, 18, pp.A642~ (2015)
- Kim HA, "Cell death and apoptosis in osteoarthritic cartilage", Curr Drug Targets, 8, pp.333~345 (2007)
- Speziali A, "Chondropenia : current concept review", Musculoskelet Surg, 99, pp.189~200 (2015)
- Kim HA, "Relationship between chondrocyte apoptosis and matrix depletion in human articular cartilage", J Rheumatol, 28, pp.2038~2045 (2001)
- Barabutis N, "Growth hormone-releasing hormone : extrapituitary effects in physiology and pathology", Cell Cycle, 9, pp.4110~4116 (2010)
- Granata R, "Peripheral activities of growth hormone-releasing hormone", J Endocrinol Invest, 39, pp.721~727 (2016)
- Lee A, "Potential role for growth hormone-releasing hormone in triple-negative breast cancer", Peptides, 92, pp.46~47 (2017)
- Munoz-Moreno L, "Anti-proliferative and pro-apoptotic effects of GHRH antagonists in prostate cancer", Oncotarget, 7, pp.52195~52206 (2016)
- Granata R, "Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart", Cardiovasc Res, 83, pp.303~312 (2009)
- Ludwig B, "Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic islets", Proc Natl Acad Sci U S A, 107, pp.12623~12628 (2010)
- Dioufa N, "Growth hormone-releasing hormone receptor splice variant 1 is frequently expressed in oral squamous cell carcinomas", Horm Cancer, 3, pp.172~180 (2012)
- Ma Q, "Profound actions of an agonist of growth hormone-releasing hormone on angiogenic therapy by mesenchymal stem cells", Arterioscler Thromb Vasc Biol, 36, pp.663~672 (2016)
- Huang M, "Meta-analysis of urinary C-terminal telopeptide of type II collagen as a biomarker in osteoarthritis diagnosis", J Orthop Translat, 13, pp.50~57 (2017)
- Hoshi H, "Effect of inhibiting MMP13 and ADAMTS5 by intra-articular injection of small interfering RNA in a surgically induced osteoarthritis model of mice", Cell Tissue Res, 368, pp.379~387 (2017)
- Malemud CJ, "Negative regulators of JAK", STAT signaling in rheumatoid arthritis and osteoarthritis, 2017, pp.18, ~
- Xia X, "Growth hormone-releasing hormone and its analogues : significance for MSCs-mediated angiogenesis", Stem Cells Int, 2016, pp.8737589~ (2016)